McCaffrey, Erin F. https://orcid.org/0000-0001-7241-1798
Donato, Michele https://orcid.org/0000-0002-9968-6027
Keren, Leeat
Chen, Zhenghao
Delmastro, Alea https://orcid.org/0000-0002-7959-3165
Fitzpatrick, Megan B. https://orcid.org/0000-0001-7040-8018
Gupta, Sanjana
Greenwald, Noah F. https://orcid.org/0000-0002-7836-4379
Baranski, Alex
Graf, William https://orcid.org/0000-0002-4264-9479
Kumar, Rashmi
Bosse, Marc
Fullaway, Christine Camacho https://orcid.org/0000-0002-4924-591X
Ramdial, Pratista K.
Forgó, Erna
Jojic, Vladimir
Van Valen, David https://orcid.org/0000-0001-7534-7621
Mehra, Smriti
Khader, Shabaana A. https://orcid.org/0000-0002-9545-4982
Bendall, Sean C. https://orcid.org/0000-0003-1341-2453
van de Rijn, Matt
Kalman, Daniel
Kaushal, Deepak https://orcid.org/0000-0003-3521-1257
Hunter, Robert L.
Banaei, Niaz
Steyn, Adrie J. C.
Khatri, Purvesh https://orcid.org/0000-0002-4143-4708
Angelo, Michael https://orcid.org/0000-0003-1531-5067
Funding for this research was provided by:
U.S. Department of Defense (W81XWH2110143)
U.S. Department of Defense (W81XWH-18-1-0253)
U.S. Department of Defense (W81XWH1910235)
Wellcome Trust
Bill and Melinda Gates Foundation (OPP1113682)
U.S. Department of Health & Human Services | National Institutes of Health (5DP5OD01982205)
U.S. Department of Health & Human Services | National Institutes of Health (1R01CA24063801A1)
U.S. Department of Health & Human Services | National Institutes of Health (5R01AG06827902)
U.S. Department of Health & Human Services | National Institutes of Health (5UH3CA24663303)
U.S. Department of Health & Human Services | National Institutes of Health (5R01CA22952904)
U.S. Department of Health & Human Services | National Institutes of Health (1U24CA22430901)
U.S. Department of Health & Human Services | National Institutes of Health (5R01AG05791504)
U.S. Department of Health & Human Services | National Institutes of Health (5R01AG05628705)
U.S. Department of Health & Human Services | National Institutes of Health (5T32AI007290)
Cancer Research Institute
Parker Center for Cancer Immunotherapy, Breast Cancer Research Foundation
National Science Foundation (2017242837)
Damon Runyon Cancer Research Foundation (DRG-2292-17)
European Molecular Biology Organization (ALTF 1128–2016)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA246880-01)
CRDF Global
South African Medical Research Council
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1U19AI109662)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI057229)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R01AI125197)
Dr. Ralph and Marian Falk Medical Research Trust
Article History
Received: 25 May 2021
Accepted: 14 December 2021
First Online: 20 January 2022
Change Date: 11 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41590-022-01178-2
Competing interests
: M.A. and S.C.B. are inventors on patent US20150287578A1, which covers the mass spectrometry approach utilized by MIBI-TOF to detect elemental reporters in tissue using secondary ion mass spectrometry. M.A. and S.C.B. are board members and shareholders in IonPath, which develops and manufactures the commercial MIBI-TOF platform. E.F.M. has previously consulted for IonPath. The remaining authors declare no competing interests.